Cargando…
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling
BACKGROUND: MTHFD2 is a folate-coupled metabolic enzyme, which has been proved to participant in the metabolic reprogramming and tumor cell-sustaining proliferative capacity. However, the function of MTHFD2 in the development of ovarian cancer and its potential molecular mechanisms is still unclear....
Autores principales: | Cui, Xiangrong, Su, Huancheng, Yang, Jiaolin, Wu, Xueqing, Huo, Kai, Jing, Xuan, Zhang, Sanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827288/ https://www.ncbi.nlm.nih.gov/pubmed/35135596 http://dx.doi.org/10.1186/s13048-022-00954-w |
Ejemplares similares
-
Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling
por: Cui, Xiangrong, et al.
Publicado: (2021) -
Endometrial microbiota from endometrial cancer and paired pericancer tissues in postmenopausal women: differences and clinical relevance
por: Wang, Lili, et al.
Publicado: (2022) -
Triglyceride regulate ACE2 level through MTHFD1
por: Ma, Xiaohua, et al.
Publicado: (2021) -
Genetic of preimplantation diagnosis of dysmorphic facial features and intellectual developmental disorder (CHDFIDD) without congenital heart defects
por: Cui, Xiangrong, et al.
Publicado: (2022) -
MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation
por: Sdelci, Sara, et al.
Publicado: (2019)